What is the Drug Abuse Screening Test (DAST-10)?
Nearly one in five people have used illegal drugs or...
Read article
The PMQ helps screen pain patients for behaviors associated with a risk of substance abuse. It can be used alongside additional questionnaires and cognitive tasks in Creyos Health for a fuller picture of cognitive health.
Healthcare providers can administer the PMQ questionnaire alongside cognitive tasks and get real-time results—all from the same platform.
Patients can complete the PMQ screening tool in person or at home, improving access to assessment and treatment.
Providers can benchmark and continuously evaluate pain patients symptom progression with a centralized health record that includes longitudinal data.
2.1 million Americans and 16 million people worldwide experience opioid use disorder. By effectively screening pain patients for their risk of potential addiction, healthcare providers can intervene early and address pain, changes in cognitive function, and substance abuse concerns.
Review our guide below for a complete list of standardized questionnaires available in Creyos.
The PMQ offered through Creyos is a 26-question self-report questionnaire designed to screen for risk of pain medication abuse.
When administered alongside measures of cognitive performance, it allows clinicians to:
The PMQ is not a pre-treatment tool. Rather, it is an opioid screening instrument to measure the risk of patients who are already taking opioids. This helps clinicians spot potential opioid misuse and intervene for better treatment outcomes.
The PMQ questionnaire contains 26 questions related to how a patient feels about their pain or current medication at the time of assessment. It can be administered in person through the Creyos Health platform on an in-clinic device or remotely through a provided link.
Creyos Health automatically scores PMQ results and provides reports. Higher scores indicate a greater risk of pain medication misuse.
Healthcare providers can discuss results with patients and combine with other assessments and cognitive tasks to build a complete picture of the patient’s health.
Chronic pain can have a profound impact on cognitive function, creating challenges with memory, attention, problem solving, and decision making. While pain medications can help reduce pain and improve quality of life, they can also cause significant cognitive impairment when misused or abused.
Creyos Health’s neuropsychological tasks can help clinicians monitor patients with chronic pain and the cognitive effects of pain medication over the course of treatment. These tasks can be used alongside the PMQ and additional questionnaires like the AUDIT, the DAST-10, and the ORT, which are all available within the Creyos Health platform.
The PMQ questionnaire was developed by Laura L. Adams et al. in 2004 as a way to easily identify patients who need a more thorough assessment for risk of opioid medication misuse or substance abuse.
The PMQ questionnaire should be used as a screening tool to assist primary care providers, mental health professionals, addictions or pain specialists, or others in understanding pain medication use and abuse and monitoring behaviors over time. Any conclusions drawn from the PMQ should be paired with further assessment, such as clinical interviews and observations, additional mental health examinations or assessments, and evaluations of the patient’s level of distress, functional impairment, and/or family history.
Nearly one in five people have used illegal drugs or...
Read article
Up to 29% of patients being treated for chronic pain misuse...
Read article
16 million Americans over the age of 12 abuse prescription...
Read article